Stock overview
Microbot Medical Inc. (MBOT)
$1.71-2.84%Aft $1.76 (+2.75%)Market cap $114.9M
Stock Scorer
Scoring…
Analyst consensus
$7.00
- Analysts3
- Implied upside+309.4%
- Target range$4.00 to $12.00
Analyst estimates are opinions, not forecasts of what the stock will do.
SEC filings
| Form | Filed | Description |
|---|---|---|
| 8-K | July 21, 2026 | 8-K |
| 8-K | July 7, 2026 | 8-K |
| 8-K | June 30, 2026 | 8-K |
| 8-K | June 25, 2026 | 8-K |
| 8-K | June 23, 2026 | 8-K |
| 8-K | June 16, 2026 | 8-K |
| 8-K | June 9, 2026 | 8-K |
| 8-K | June 2, 2026 | 8-K |
Our MBOT coverage
Frequently asked questions
What do analysts expect for MBOT?
3 analysts cover Microbot Medical Inc. (MBOT). The consensus rating is Strong buy and the average price target is $7.00, in a range of $4.00 to $12.00.
Are insiders buying or selling MBOT?
We have no qualifying Form 4 insider purchases or sales on record for Microbot Medical Inc. (MBOT). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see MBOT SEC filings?
Recent filings are listed on this page, newest first. The latest is a 8-K filed July 21, 2026.
Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.
